Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 12 Papillomavirus Infections 11 Neoplasms 10 Breast Neoplasms 9 Uterine Cervical Dysplasia 7 Persistent Infection 5 Condylomata Acuminata 5 Prostatic Neoplasms 4 Melanoma 4 Anus Neoplasms 4 Vulvar Neoplasms 3 Lung Neoplasms 3 Herpes Zoster 3 Glioblastoma 3 Carcinoma, Non-Small-Cell Lung 3 Vaginal Neoplasms 2 Sarcoma 2 Neuroblastoma 2 Neoplasm Metastasis 2 Influenza, Human 2 HIV Infections 2 Glioma 2 Colonic Neoplasms 2 Breast Neoplasms, Male 2 Wilms Tumor 1 Whooping Cough 1 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Tetanus 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

Fluorouracil 498 Bevacizumab 476 Oxaliplatin 450 Leucovorin 442 Irinotecan 408 Cetuximab 318 Capecitabine 317 pembrolizumab 142 Folfox protocol 128 Panitumumab 117 regorafenib 105 Colonoscopy 88 Nivolumab 82 IFL protocol 81 Drug Therapy 77 trifluridine tipiracil drug combination 73 Radiotherapy 66 HMPL-013 65 Blood Specimen Collection 52 Gemcitabine 49 Specimen Handling 47 Standard of Care 45 Neoadjuvant Therapy 45 Magnetic Resonance Spectroscopy 44 Biopsy 44 Chemotherapy, Adjuvant 41 Trifluridine 40 atezolizumab 39 Cyclophosphamide 39 Surveys and Questionnaires 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Neoplasms × Vaccines × Clear all

NCT06522919 2025-01-28

CombiCoR-Vax

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡